. 2017 May 1;18:146. doi: 10.1186/s12882-017-0551-4

Table 4.

Characteristics of women receiving renal replacement therapy

Case No	Etiology of AKI	Renal replacement	Maternal outcome	Prenatal outcome
1	Tetralogy of Fallot, heart failure	CVVH	Recovery	Premature infant
2	Preeclampsia, placental abruption	HDF	Recovery completely	Stillbirth
3	Epidemic hemorrhagic fever	HD	Recovery completely	Loss follow up
4	Chronic kidney disease	HD	ESRD	Induced labor
5	Amniotic fluid embolism	CVVH	Death	Term infant
5	Postpartum hemorrhage	CVVH	Death	Term infant
6	Preeclampsia, pneumonia	CVVH	Recovery	Premature infant
7	Amniotic fluid embolism	CVVH	Death	Term infant
	Postpartum hemorrhage
8^a	AFLP	CVVH + PE	Recovery completely	Small-for-date infant
9	Postpartum hemorrhage	CVVH	Recovery	Without data
10	Preeclampsia, peripartum cardiomyopathy, heart failure	CVVH	Chronic kidney disease	Premature infant
11	Postpartum hemorrhage	CVVH	Recovery	Term infant
12	HELLP	CVVH + PE	Recovery	Stillbirth
13	AFLP	CVVH + PE	Recovery	Stillbirth
14	Postpartum hemorrhage,shock	CVVH	Death	Premature infant
15^a	HELLP	CVVH	Recovery completely	Stillbirth
16	Chronic kidney disease	CVVH	ESRD	Stillbirth
17	AFLP, MODS	CVVH + PE	Death	Term infant
18	Hemorrhagic shock from a ruptured ectopic pregnancy	CVVH	Death
19	Postpartum hemorrhage	CVVH + PE	Death	Term infant
19	Amniotic fluid embolism	CVVH + PE	Death	Term infant
20	Postpartum hemorrhage, MODS	CVVH	Death	Term infant
21	HUS post Escherichia coli infection	CVVH + PE	Improved condition	Term infant

^aTwin pregnancy; AFLP fatty liver of pregnancy, MODS Multiple organ dysfunction syndrome, HUS hemolytic uremic syndrome, CVVH continuous veno-venous hemofiltration, HD hemodialysis, HDF hemodiafiltration, PE plasma exchange, ESRD end stage kidney disease